Sitrin Capital Management’s AbbVie ABBV Stock Holding History

Sitrin Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.82M	Sell	27,088 -289	-1%	-$62.2K	3.02%	14
2026 Q1	$5.95M	Sell	27,377 -446	-2%	-$98.9K	2.98%	17
2025 Q4	$6.36M	Buy	27,823 +456	+2%	+$104K	3.02%	17
2025 Q3	$6.34M	Buy	27,367 +23,435	+596%	+$4.77M	3.04%	16
2025 Q2	$730K	Hold	3,932	–	–	0.37%	33
2025 Q1	$824K	Hold	3,932	–	–	0.44%	33
2024 Q4	$699K	Sell	3,932 -10	-0.3%	-$1.84K	0.35%	34
2024 Q3	$778K	Buy	+3,942	New	+$736K	0.39%	34
2020 Q2	–	Sell	-3,932	Closed	-$300K	–	33
2020 Q1	$300K	Hold	3,932	–	–	0.18%	33
2019 Q4	$348K	Hold	3,932	–	–	0.18%	33
2019 Q3	$298K	Hold	3,932	–	–	0.16%	35
2019 Q2	$286K	Hold	3,932	–	–	0.15%	34
2019 Q1	$317K	Hold	3,932	–	–	0.17%	35
2018 Q4	$362K	Hold	3,932	–	–	0.22%	33
2018 Q3	$372K	Hold	3,932	–	–	0.2%	33
2018 Q2	$364K	Hold	3,932	–	–	0.21%	35
2018 Q1	$372K	Hold	3,932	–	–	0.24%	35
2017 Q4	$380K	Hold	3,932	–	–	0.24%	35
2017 Q3	$349K	Hold	3,932	–	–	0.22%	35
2017 Q2	$285K	Hold	3,932	–	–	0.19%	34
2017 Q1	$256K	Hold	3,932	–	–	0.18%	35
2016 Q4	$246K	Hold	3,932	–	–	0.19%	35
2016 Q3	$248K	Hold	3,932	–	–	0.19%	35
2016 Q2	$243K	Hold	3,932	–	–	0.2%	34
2016 Q1	$225K	Hold	3,932	–	–	0.18%	35
2015 Q4	$219K	Buy	+3,932	New	+$226K	0.19%	35

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sitrin Capital Management's ABBV Position: Q2 2026 in Review

Sitrin Capital Management reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $62.2K and leaving 27,088 shares worth $6.82M. The position accounts for 3.02% of the portfolio, ranked #14.

Sitrin Capital Management first reported a position in ABBV in Q4 2015 and has held it in 26 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Sitrin Capital Management held 27,088 shares of AbbVie worth $6.82M as of Q2 2026.
Sitrin Capital Management sold 289 AbbVie shares in Q2 2026, an estimated $62.2K.
AbbVie made up 3.02% of Sitrin Capital Management's portfolio in Q2 2026, its #14 holding.
Sitrin Capital Management first reported a position in AbbVie in Q4 2015 and has held it in 26 quarters since.
4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sitrin Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.